Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
SK-BR-3 | Palbociclib | 0.31623 | uM | 3 | 156.25 | 80.34 | 98.00 | 89.50 | 1.0950 | 2.5818 |
SK-BR-3 | Taxol | 0.1 | uM | 3 | 156.25 | 80.34 | 82.00 | 89.50 | 0.9162 | 0.1400 |
SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 70.00 | 89.50 | 0.7821 | -0.5874 | |
SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 65.00 | 89.50 | 0.7263 | -0.7436 | |
SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 69.00 | 89.50 | 0.7710 | -0.6238 | |
SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 71.00 | 89.50 | 0.7933 | -0.5480 | |
SK-BR-3 | Methotrexate | 0.31623 | uM | 3 | 156.25 | 80.34 | 89.00 | 89.50 | 0.9944 | 0.9293 |
SK-BR-3 | Palbociclib | 19.9526 | uM | 3 | 156.25 | 80.34 | 109.00 | 89.50 | 1.2179 | 6.0929 |
SK-BR-3 | Methotrexate | 0.0016596 | uM | 3 | 156.25 | 80.34 | 80.00 | 89.50 | 0.8939 | -0.0272 |
SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 81.00 | 89.50 | 0.9050 | 0.0536 | |
SK-BR-3 | Taxol | 0.31623 | uM | 3 | 156.25 | 80.34 | 72.00 | 89.50 | 0.8045 | -0.5055 |
SK-BR-3 | Palbociclib | 0.01 | uM | 3 | 156.25 | 80.34 | 60.00 | 89.50 | 0.6704 | -0.8467 |
SK-BR-3 | Taxol | 1 | uM | 3 | 156.25 | 80.34 | 78.00 | 89.50 | 0.8715 | -0.1732 |
SK-BR-3 | Taxol | 0.0031623 | uM | 3 | 156.25 | 80.34 | 90.00 | 89.50 | 1.0056 | 1.0729 |
SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 155.00 | 89.50 | 1.7318 | 67.0548 | |
SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 143.00 | 89.50 | 1.5978 | 39.5600 | |
SK-BR-3 | Palbociclib | 0.031623 | uM | 3 | 156.25 | 80.34 | 69.00 | 89.50 | 0.7710 | -0.6238 |
SK-BR-3 | Methotrexate | 0.0033113 | uM | 3 | 156.25 | 80.34 | 104.00 | 89.50 | 1.1620 | 4.2462 |
SK-BR-3 | Methotrexate | 1 | uM | 3 | 156.25 | 80.34 | 113.00 | 89.50 | 1.2626 | 7.9402 |
SK-BR-3 | Omipalisib | 0.1 | uM | 3 | 156.25 | 80.34 | 84.00 | 89.50 | 0.9386 | 0.3309 |
SK-BR-3 | Taxol | 0.001 | uM | 3 | 156.25 | 80.34 | 77.00 | 89.50 | 0.8603 | -0.2389 |
SK-BR-3 | Omipalisib | 0.31623 | uM | 3 | 156.25 | 80.34 | 71.00 | 89.50 | 0.7933 | -0.5480 |
SK-BR-3 | Omipalisib | 0.031623 | uM | 3 | 156.25 | 80.34 | 74.00 | 89.50 | 0.8268 | -0.4104 |
SK-BR-3 | Methotrexate | 10 | uM | 3 | 156.25 | 80.34 | 89.00 | 89.50 | 0.9944 | 0.9293 |
SK-BR-3 | Omipalisib | 0.01 | uM | 3 | 156.25 | 80.34 | 75.00 | 89.50 | 0.8380 | -0.3573 |